153 related articles for article (PubMed ID: 29924226)
21. Clinical features of hypereosinophilic syndrome: FIP1L1-PDGFRA fusion gene-positive disease is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroid.
Miyazawa K; Kakazu N; Ohyashiki K
Int J Hematol; 2007 Jan; 85(1):5-10. PubMed ID: 17261495
[TBL] [Abstract][Full Text] [Related]
22. Hyperimmunoglobulinemia E syndrome in HIV infection.
Blanche P; Bachmeyer C; Buvry C; Sicard D
J Am Acad Dermatol; 1997 Jan; 36(1):106-7. PubMed ID: 8996273
[No Abstract] [Full Text] [Related]
23. Secondary hypereosinophilic syndrome: an unusual manifestation in a patient with syringotropic mycosis fungoides and human immunodeficiency virus infection.
Reguero-Del Cura L; Pérez-Paredes MG; Cortés-Vázquez MA; López-Sundh AE; González-Vela MC; Gómez-Fernández C; González-López MA
Australas J Dermatol; 2021 May; 62(2):213-216. PubMed ID: 33421095
[TBL] [Abstract][Full Text] [Related]
24. Eosinophilic cellulitis as a cutaneous manifestation of idiopathic hypereosinophilic syndrome.
Fujii K; Tanabe H; Kanno Y; Konishi K; Ohgou N
J Am Acad Dermatol; 2003 Dec; 49(6):1174-7. PubMed ID: 14639412
[TBL] [Abstract][Full Text] [Related]
25. Myeloproliferative hypereosinophilic syndrome presenting as cardiac failure and response to imatinib.
Desai N; Morkhandikar S; Sahay R; Jijina F; Patil P
Am J Ther; 2014; 21(2):e35-7. PubMed ID: 24603276
[TBL] [Abstract][Full Text] [Related]
26. Case of hypereosinophilic syndrome with cutaneous necrotizing vasculitis.
Hayashi M; Kawaguchi M; Mitsuhashi Y; Suzuki T
J Dermatol; 2008 Apr; 35(4):229-33. PubMed ID: 18419681
[TBL] [Abstract][Full Text] [Related]
27. Erythroderma: a clinical and prognostic study.
Li J; Zheng HY
Dermatology; 2012; 225(2):154-62. PubMed ID: 23037884
[TBL] [Abstract][Full Text] [Related]
28. [Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].
Moles MP; Landry J; Roche-Lestienne C; Godon A; Schmidt-Tanguy A; Gardembas M; Le Clech C; Verret JL; Zandecki M; Blanchet O
Ann Biol Clin (Paris); 2005; 63(3):317-22. PubMed ID: 15951264
[TBL] [Abstract][Full Text] [Related]
29. Erythroderma as a paraneoplastic manifestation of small cell lung cancer.
Zervakis SG; Spernovasilis N; Boutakoglou E; Panagiotakis S; Thomopoulou K; Samonis G
Curr Probl Cancer; 2020 Apr; 44(2):100499. PubMed ID: 31493907
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic Hypereosinophilic Syndrome With Cutaneous Manifestations and Flame Figures: A Spectrum of Eosinophilic Dermatoses Whose Features Overlap With Wells' Syndrome.
Smith SM; Kiracofe EA; Clark LN; Gru AA
Am J Dermatopathol; 2015 Dec; 37(12):910-4. PubMed ID: 25839890
[TBL] [Abstract][Full Text] [Related]
31. Hypereosinophilic syndrome in an atopic patient.
Neve S; Beukers S; Kirtschig G
Clin Exp Dermatol; 2009 Dec; 34(8):e643-6. PubMed ID: 19538189
[TBL] [Abstract][Full Text] [Related]
32. Detection of FIP1L1-PDGFRA fusion gene-positive cells in the skin lesion of a patient with hypereosinophilic syndrome.
Kitayama S; Makino T; Yoto A; Mori S; Furukawa F; Torai R; Mizawa M; Shimizu T
Clin Exp Dermatol; 2023 Mar; 48(4):364-367. PubMed ID: 36763740
[TBL] [Abstract][Full Text] [Related]
33. Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias.
Vandenberghe P; Wlodarska I; Michaux L; Zachée P; Boogaerts M; Vanstraelen D; Herregods MC; Van Hoof A; Selleslag D; Roufosse F; Maerevoet M; Verhoef G; Cools J; Gilliland DG; Hagemeijer A; Marynen P
Leukemia; 2004 Apr; 18(4):734-42. PubMed ID: 14973504
[TBL] [Abstract][Full Text] [Related]
34. A rare case of hypereosinophilic syndrome presenting with unilateral proptosis and torticollis.
Das JK; Gupta K; Deshmukh S; Shrivastava R
Indian J Ophthalmol; 2018 Oct; 66(10):1508-1511. PubMed ID: 30249857
[TBL] [Abstract][Full Text] [Related]
35. Central nervous system involvement of hypereosinophilic syndrome: a report of 10 cases and a literature review.
Lee D; Ahn TB
J Neurol Sci; 2014 Dec; 347(1-2):281-7. PubMed ID: 25455301
[TBL] [Abstract][Full Text] [Related]
36. Imatinib responsive erythrocytosis in a patient with FIP1L1::PDGFRA rearranged myeloid neoplasm with hypereosinophilia - Another manifestation of a stem cell neoplasm.
Virk H; Rathore S; Anshu A; Jamwal M; Lad D; Das R; Sreedharanunni S
Leuk Res; 2022 Oct; 121():106922. PubMed ID: 35933911
[No Abstract] [Full Text] [Related]
37. Lymphomatoid papulosis associated with myeloid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement: Successful imatinib treatment in two cases.
Bellani V; Croci GA; Bucelli C; Maronese CA; Alberti S; Iurlo A; Cattaneo D
J Dermatol; 2023 Oct; 50(10):1330-1334. PubMed ID: 37248740
[TBL] [Abstract][Full Text] [Related]
38. Case records of the Massachusetts General Hospital. Case 24-2013. A 53-year-old woman with erythroderma, pruritus, and lymphadenopathy.
Carter JB; Barnes JA; Niell BL; Nardi V
N Engl J Med; 2013 Aug; 369(6):559-69. PubMed ID: 23924007
[No Abstract] [Full Text] [Related]
39. [Icthyosiform erythroderma: atypical manifestation of sarcoidosis].
Amal S; Khadir K; Agzour K; Nejjam F; Badre L; Sqalli S; Lakhdar H
Ann Dermatol Venereol; 2000 Jan; 127(1):64-6. PubMed ID: 10717566
[TBL] [Abstract][Full Text] [Related]
40. [Endomyocardial disease as the first manifestation of hypereosinophilic syndrome].
Poreba M; Rostoff P; Konduracka E; Pikul P; Rucińska M; Pasowicz M; Piwowarska W
Kardiol Pol; 2010 Apr; 68(4):440-5. PubMed ID: 20425707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
